Basic Information
| LncRNA/CircRNA Name | CCAT2 |
| Synonyms | NA |
| Region | GRCh38_8:127400399-127402150 |
| Ensemble | ENSG00000280997 |
| Refseq | NR_109834 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, Luciferase reporter assay, Western blot |
| Sample | HCC tissues and HCC cell lines |
| Expression Pattern | up-regulated |
| Function Description | LncRNA CCAT2 were remarkably up-regulated in HCC tissues and HCC cell lines. |
| Pubmed ID | 30922920 |
| Year | 2019 |
| Title | Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1. |
External Links
| Links for CCAT2 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |